BRITTANY MCCRARY: Open Payments
NPI 1720612120 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 8 payments from 6 companies in 2025. Trend: 2023 $71 · 2024 $193 · 2025 $921
Food & beverage: $491Consulting: $430
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 3 | $590 |
| Agios Pharmaceuticals, Inc. | 1 | $138 |
| AstraZeneca Pharmaceuticals LP | 1 | $110 |
| Immunocore Limited | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
Products named: FERRIPROX, PYRUKYND, WAINUA, KIMMTRAK, KEYTRUDA, TAVALISSE.
Industry payments across NY — which companies pay providers there.
